EN DE
Watch Pony Testing International Group Co for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Pony Testing International Group Co (300887) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Pony Testing International Group Co stock ¥1.28, price ¥6.05, that is 78.8% below the price, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials CN · ISIN CNE1000047Y1

PT Pony Testing International Group Co logo Thin data Nov 17, 2026

Pony Testing International Group Co

300887 · SHE

Far too expensive (fair value 79% below the price) and falling price, but company just good enough: meets 1 of 3 rules.

Get notified free when this changes
Low debt 
Generates free cash flow 
Quality 46/100 
Revenue last quarter 12% below a year ago. 
Fair value ¥1.28 · Strongly overvalued 
Falling price (downtrend) 
Weak Growth (revenue 5y −0.9 %/yr in CNY) 
Loss-making · -13.2% net margin (TTM) 
Trails peers (2/11) 
Narrow moat 8/100 · thin data
Thin data 
Watch Pony Testing International Group Co for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥25.78 ¥5.95 Fair Value ¥1.28 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

60‑month range ¥5.95 – ¥25.78 · fair‑value band ¥1.24 – ¥1.34 · the ¥6.05 price screens above the ¥1.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.

Follow Pony Testing International Group Co in your weekly email

Every Wednesday you see whether Pony Testing International Group Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Pony Testing Co., Ltd. provides testing, measurement, calibration, inspection, evaluation, factory inspection, and other professional one-stop technical solutions in China.

Show moreShow less

The company offers biopharmaceutical CRO/CDMO and drug testing services; medical device testing; medical testing/pathological diagnosis; toxicology and pathology experiments; food/liquor/beverage testing; agricultural product testing; and health product testing services.

It also provides drinking water/mineral water and other packaged water products testing; ecological environment monitoring; environmental consulting and operation/environmental stewardship/identification of hazardous waste properties; and energy saving and carbon reduction/carbon measurement/carbon footprint/carbon neutralization/ESG services.

In addition, the company offers occupational health/public health/school health; nuclear and radiation/radiation health; automobile whole vehicle/parts/new energy vehicle testing; new energy vehicle power battery and energy storage battery detection; electronic and electrical testing/electrical equipment testing; evaluation of transport conditions of dangerous goods; e-cigarette testing and certification; cosmetics testing; and human efficacy test of cosmetics services.

Further, it provides consumer goods/textiles/toys/oil products testing; ink coating/chemical product testing; special equipment inspection and testing; inspection of goods/factory; certification service/two-party audit; disinfection and sterilization; nondestructive testing; and training services.

Additionally, the company offers e-cigarette SDS, UFI, PCN registration; electromagnetic compatibility testing; e-commerce solutions; rapid inspection; detection of IgM, IgG and neutralizing antibody of new coronavirus; Software testing and evaluation/network security; environmental reliability test; disinfection and sterilization; and non-destructive testing.

The company was founded in 2002 and is headquartered in Beijing, China.

Stock analysis

Pony Testing International Group Co (300887) currently trades at ¥6.05, while our model-based Fair Value estimate is ¥1.28, 79% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of ¥2.14 per share, and 0 of the 9 models we run sit above the ¥6.05 price.

Bear case: the DCF Models group reads lowest at ¥1.27, and 9 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: ¥1.24 (bear) to ¥1.34 (bull), the price of ¥6.05 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Pony Testing International Group Co reported revenue of 1.4B CNY in FY2025 versus 2.0B CNY in FY2021, a compound −9.2%/yr. Reported net income was −246M CNY in FY2025.

Key figures

Market cap 3.3B CNY (≈ $496M) Small · P/S ratio 2.57 · EPS (TTM) ¥−0.3200 · Dividend yield 0.1% · Net margin −13.2% · Return on equity −6.3% · Return on assets (EBIT) 3.2% (5-year average) · Operating margin −6.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 62% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −11% fair-value upside, at −79%, 300887 screens richer than that median.

Fair Value models

Bear ¥1.24 Fair Value ¥1.28 Bull ¥1.34
Price ¥6.05 · Downside -78.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ¥1.23 ¥1.27 ¥1.34 82
Growth DCF ¥1.24 ¥1.28 ¥1.33 80
5Y EBITDA Exit ¥1.88 ¥2.41 ¥3.10 77
All 9 models by family
DCF Models
FCF DCF ¥1.23 ¥1.27 ¥1.34 82
5Y Revenue Exit ¥1.19 ¥1.21 ¥1.25 74
5Y EBITDA Exit ¥1.88 ¥2.41 ¥3.10 77
10Y Revenue Exit ¥1.21 ¥1.22 ¥1.24 68
10Y EBITDA Exit ¥1.59 ¥1.90 ¥2.24 70
Multiples
EV/EBITDA ¥2.59 ¥3.09 ¥3.58 67
EV/Revenue ¥1.16 ¥1.18 ¥1.20 54
Asset-Based
NCAV (Graham) ¥1.33 ¥2.02 ¥2.53 54
Growth DCF
Growth DCF ¥1.24 ¥1.28 ¥1.33 80

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 9
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 18
Do the profits arrive as real cash?
Financial strength 90
Debt, balance sheet and risk of trouble
Investment 89
Does it invest with discipline instead of growing at any price?
Low Volatility 44
How calm the share price moves, does not count
Price momentum 13
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 21/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−11.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−28.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.9%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
14.7% (2020) → −9.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

300887 screens overvalued: fair value 79% below the price. Compare with Cintas Corporation →

Compare Pony Testing International Group Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 246 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −78.8% · Bottom 25%
Profitability
Return on assets −7.3% · Bottom 25%
Net margin (12 months) −13.2% · Bottom 25%
Operating margin (12 months) −6.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −11.9% · Bottom 25%
Dividend yield (12 months) 0.1% · Bottom 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 1.17× · Cheaper than median
P/S (12 months) 2.49× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 40
FUTURE (revenue growth)0 · sector 35
PAST (return on equity)0 · sector 36
HEALTH (low debt)100 · sector 93
DIVIDEND (yield)1 · sector 55

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
RB Global, Inc RBA C$136.06 C$149.80 +10% vs 300887
Copart, Inc CPRT $32.08 $35.29 +10% vs 300887
Wolters Kluwer N.V WKL €90.84 €98.06 +8% vs 300887
Global Payments Inc GPN $89.82 $87.83 −2% vs 300887
Brambles Limited BXB A$22.15 A$19.81 −11% vs 300887
Cintas Corporation CTAS $224.16 $192.08 −14% vs 300887
Rentokil Initial plc RTO $24.19 $19.63 −19% vs 300887
Thomson Reuters Corporation TRI $108.29 $70.75 −35% vs 300887
Aramark ARMK $55.37 $29.34 −47% vs 300887
UL Solutions Inc ULS $78.13 $33.46 −57% vs 300887

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Pony Testing International Group Co: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Pony Testing International Group Co Fair Value". https://www.fairvalue-calculator.com/stock/300887

Frequently asked questions

Is Pony Testing International Group Co (300887) overvalued or undervalued?
As of Nov 17, 2026, our model estimates a fair value of ¥1.28 versus a price of ¥6.05, about 79% lower (overvalued).
What is the fair value of 300887?
Our model-based fair value for Pony Testing International Group Co is ¥1.28 (as of Nov 17, 2026), built from audited fundamentals. The current price: ¥6.05.
What is the quality score of 300887?
Pony Testing International Group Co has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pony Testing International Group Co (300887)?
Our model-based price target is the fair value of ¥1.28 (as of Nov 17, 2026) from 9 valuation models. Cautious scenario ¥1.24, optimistic scenario ¥1.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Pony Testing International Group Co stock forecast for 2026?
Our models put fair value at ¥1.28, about 79% lower versus a price of ¥6.05 (overvalued). Cautious scenario ¥1.24, optimistic scenario ¥1.34. The calculation is refreshed regularly with new filings.
What is the revenue of Pony Testing International Group Co (300887)?
Pony Testing International Group Co reported trailing-twelve-month revenue of about 1.3B CNY (latest available figure, as of Nov 17, 2026).
Does Pony Testing International Group Co pay a dividend?
Pony Testing International Group Co currently shows a dividend yield of 0.07% relative to its recent price (as of Nov 17, 2026).
How much is the dividend of Pony Testing International Group Co (300887)?
Pony Testing International Group Co has a dividend yield of 0.1%.
What is the intrinsic value of Pony Testing International Group Co (300887)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pony Testing International Group Co it is ¥1.28 per share (as of Nov 17, 2026), against a price of ¥6.05. It is the blended result of 9 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Pony Testing International Group Co stock overvalued or undervalued in 2026?
As of Nov 17, 2026, 300887 trades above its calculated fair value: price ¥6.05, fair value ¥1.28, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300887?
No. The price is what the market pays today (¥6.05); the fair value is what the company's own numbers justify (¥1.28). For Pony Testing International Group Co the two are ¥4.77 per share apart. That gap is exactly why we show both numbers side by side.
How much is Pony Testing International Group Co worth?
The market values Pony Testing International Group Co at about 3.3B CNY (market capitalisation, as of Nov 17, 2026). Per share that is ¥6.05; our models calculate a fair value of ¥1.28 per share.
What do the bullish and bearish scenarios say about 300887?
Our models span a range for Pony Testing International Group Co: cautious scenario ¥1.24, base ¥1.28, optimistic ¥1.34 per share (as of Nov 17, 2026, price ¥6.05). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Pony Testing International Group Co (300887)?
Balance-sheet figures for Pony Testing International Group Co (as of Nov 17, 2026): return on equity −6.3%, debt of 0.01 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is 300887 from its 52-week high?
Pony Testing International Group Co trades at ¥6.05, about 62% below its 52-week high of ¥15.97 and at the low of ¥6.05 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ¥1.28 is for.
Which stocks are comparable to Pony Testing International Group Co?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pony Testing International Group Co stock attractive at the current price?
The data as of Nov 17, 2026: price ¥6.05, calculated fair value ¥1.28 (−79%), Quality Score 46/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300887 calculated?
We run Pony Testing International Group Co through 9 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of ¥1.28 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Pony Testing International Group Co itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pony Testing International Group Co (300887)?
The closing price on Nov 16, 2026 was ¥6.05. Our model-based fair value is ¥1.28, about 79% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pony Testing International Group Co right now?
The price sits above even our optimistic bull case (¥1.34). The favourable scenario is already priced in. Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (¥1.24 to ¥1.34), unusually little disagreement for a valuation.

Key figures of Pony Testing International Group Co

How large is the market capitalisation of Pony Testing International Group Co (300887)?
The market capitalisation of Pony Testing International Group Co is 3.3B CNY (≈ $496M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Pony Testing International Group Co (300887)?
The price-to-sales ratio of Pony Testing International Group Co is 2.57 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Pony Testing International Group Co (300887)?
Earnings per share at Pony Testing International Group Co are ¥−0.3200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Pony Testing International Group Co (300887)?
The dividend yield of Pony Testing International Group Co is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Pony Testing International Group Co (300887)?
The net margin of Pony Testing International Group Co is −13.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pony Testing International Group Co (300887)?
The return on equity (ROE) of Pony Testing International Group Co is −6.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pony Testing International Group Co (300887)?
On an EBIT basis the return on assets of Pony Testing International Group Co is 3.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Pony Testing International Group Co (300887)?
The operating margin of Pony Testing International Group Co is −6.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Pony Testing International Group Co (300887)?
Revenue at Pony Testing International Group Co is down 11.9% versus a year earlier (3y avg −28.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Pony Testing International Group Co (300887)?
Earnings per share at Pony Testing International Group Co are down 86.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Pony Testing International Group Co (300887) generate?
The free cash flow of Pony Testing International Group Co is 3.1M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Pony Testing International Group Co in the live analysis

One click puts Pony Testing International Group Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.